Additional value of integrated PET/CT over PET alone in the initial staging and follow up of head and neck malignancy

Annals of Nuclear Medicine

Volumn 24, Issue 2, 2010, Pages 77-82

  Ishikita, Tomohiro ^a   Oriuchi, Noboru ^a   Higuchi, Tetsuya ^a   Miyashita, Go ^a   Arisaka, Yukiko ^a   Paudyal, Bishnuhari ^a   Paudyal, Pramila ^a   Hanaoka, Hirofumi ^a   Miyakubo, Mitsuyuki ^a   Nakasone, Yoshiki ^a   Negishi, Akihide ^a   Yokoo, Satoshi ^a   Endo, Keigo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Diagnostic performance; FDG PET; Head and neck cancer; PET CT; Staging

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER RELAPSE; CANCER STAGING; CERVICAL LYMPH NODE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; FEMALE; FISHER EXACT TEST; FOLLOW UP; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRIMARY TUMOR; PRIORITY JOURNAL; PROBABILITY; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77950690755     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-009-0326-5     Document Type: Article

References (20)

1. Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol. 2008;97:649-652 (Pubitemid 351812964)
2. Horiuchi M, Yasuda S, Shohtsu A, Ide M. Four cases of Warthin's tumor of the parotid gland detected with FDG PET. Ann Nucl Med. 1998;12:47-50. (Pubitemid 28182617)
3. Subramaniam RM, Durnick DK, Peller PJ. F-18 FDG PET/CT imaging of submandibular gland oncocytoma. Clin Nucl Med. 2008;33:472-474
4. 18F]-fluorodeoxyglucose positron emission tomography imaging in management of head-and-neck cancer-A long-term outcome report. Int J Radiat Oncol Biol Phys. 2008;74:9-14.
5. Yen TC, Chang JT, Ng SH, Chang YC, Chan SC, Lin KJ, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005;46:405-410
6. Goerres GW, Schmid DT, Grätz KW, von Schulthess GK, Eyrich GK. Impact of whole body positron emission tomography on initial staging and therapy in patients with squamous cell carcinoma of the oral cavity. Oral Oncol. 2003;39:547-551 (Pubitemid 36694477)
7. Kitajima K, Murakami K, Yamasaki E, Domeki Y, Tsubaki M, Sunagawa M, et al. Performance of integrated FDG-PET/contrast- enhanced CT in the diagnosis of recurrent uterine cancer: comparison with PET and enhanced CT. Eur J Nucl Med Mol Imaging. 2009;36:362-372
8. Beyer T, Townsend DW, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med. 2000;41:1369-1379 (Pubitemid 30643379)
9. Bar-Shalom R, Yefremov N, Guralnik L, Gaitini D, Frenkel A, Kuten A, et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. J Nucl Med. 2003;44:1200-1209 (Pubitemid 39655178)
10. Escott EJ. Positron emission tomography-computed tomography protocol considerations for head and neck cancer imaging. Semin Ultrasound CT MR. 2008;29:263-270
11. Bold B, Piao Y, Murata Y, Kishino M, Shibuya H. Usefulness of PET/CT for detecting a second primary cancer after treatment for squamous cell carcinoma of the head and neck. Clin Nucl Med. 2008;33:831-833
12. Deantonio L, Beldì D, Gambaro G, Loi G, Brambilla M, Inglese E, et al. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma. Radiat Oncol. 2008;3:29.
13. 18F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol. 2009;45:218-224
14. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18Ffluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008;100:712-720
15. Kato H, Kimura H, Nakajima M, Sakai M, Sano A, Tanaka N, et al. The additional value of integrated PET/CT over PET in initial lymph node staging of esophageal cancer. Oncol Rep. 2008;20:857-862
16. Yuan S, Yu Y, Chao KS, Fu Z, Yin Y, Liu T, et al. Additional value of PET/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer. J Nucl Med. 2006;47:1255-1259 (Pubitemid 47544876)
17. Martin RC, Fulham M, Shannon KF, Hughes C, Gao K, Milross C, et al. Accuracy of positron emission tomography in the evaluation of patients treated with chemoradiotherapy for mucosal head and neck cancer. Head Neck. 2009;31:244-250
18. 18F] fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys. 2008;74:1054-1061
19. Suzuki H, Hasegawa Y, Terada A, Hyodo I, Nakashima T, Nishio M, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2008;45:569-573
20. Inohara H, Enomoto K, Tomiyama Y, Yoshii T, Osaki Y, Higuchi I, et al. The role of CT and 18F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy. Acta Otolaryngol. 2009;129:893-899